Yearly Archives - 2016

14Sep

Siamab Therapeutics Presents Promising Preclinical Data at 2016 AACR Ovarian Cancer Research Symposium

Siamab Therapeutics, Inc., a biotechnology company developing novel cancer immunotherapies, today announced new pre-clinical data that showed its novel ST1 antibody drug conjugates (ADCs) target chemoresistant ovarian cancer cells and demonstrate strong efficacy in ovarian cancer models. These data were presented at the American Association for Cancer Research (AACR)’s 11th Biennial Ovarian Cancer Research Symposium 2016 in Seattle, Wash., on Monday, Sept. 12, 2016. Read more >>
Portfolio News
Read more...
07Sep

Allergan Acquires Gene Therapy Company RetroSense Therapeutics Adding First-In-Class Technology to Company’s Innovative Eye Care Pipeline

llergan plc (NYSE: AGN), a leading global pharmaceutical company, and RetroSense Therapeutics LLC, a private, clinical-stage biotechnology company focused on novel gene therapy approaches to restore vision in patients suffering from blindness, today announced that Allergan has acquired substantially all of the assets of RetroSense in an all-cash transaction. Under the terms of the transaction, Allergan has paid RetroSense a $60 million upfront payment, and has agreed to potential regulatory and commercialization milestone payments related to its lead development...
Portfolio News
Read more...
02Sep

Martin Lowenthal of The Bulfinch Group Earns Retirement Income Certified Professional Designation

Martin Lowenthal, MSIM, CLU®, ChFC®, RICP®, CLTC®, a Financial Representative of The Bulfinch Group, has passed the rigorous American College certification of Retirement Income Certified Professional, an advanced designation. Martin is only the second Bulfinch Group associate to have earned this prestigious designation. This new designation from The American College creates strategies for Advisors who are focused on the needs of the thousands of Americans reaching age 65 who need guidance in obtaining sustainable retirement income. “Martin Lowenthal’s accomplishment in obtaining...
Member News
Read more...
01Sep

Boston Harbor Angels Inc. Appoints New CEO

Boston Leading Angel Investor group Strengthens Resources Ziad Moukheiber Boston, MA Boston Harbor Angels Inc announced the appointment of Ziad H. Moukheiber as BHA’s Chief Executive Officer. “Ziad will be a great asset to our angel group. He has experience in entrepreneurship with his previous company SilverSword LLC [Acquired by NSk Inc.] he has demonstrated a unique ability to identify and nurture early stage companies with the potential to scale. Ziad has extensive customer service experience that will ensure that our members and...
Member News, Organization News
Read more...